Monday, April 06, 2020 9:56:38 AM
Press Release | 04/06/2020
JACKSON CENTER, PA / ACCESSWIRE / April 6, 2020 / Premier Biomedical, Inc. (OTCPINK:BIEI) announced a multi-faceted agreement to eliminate the Convertible Notes as an obligation of Premier, cancel the previously announced plans for a reverse split, and secure near-term funding for ongoing R&D into a potential cure for Covid-19 as well as Premier's Anti-Addiction Patch™.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM